GENO-25HYPERMUTATION AND MALIGNANT PROGRESSION IN AN EXPANDED COHORT OF TEMOZOLOMIDE-TREATED LOW-GRADE GLIOMA PATIENTSTali Mazor, J Costello, Emily G. Hamilton et al.|Neuro-Oncology|2015Cited by 2
Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancersAllison Creason, Jeremy Goecks, Julian Egger et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1